Trinity Biotech PLC (TRIB)
0.641
-0.03
(-3.97%)
USD |
NASDAQ |
Mar 28, 16:00
0.645
0.00 (0.00%)
After-Hours: 20:00
Trinity Biotech Total Assets (Quarterly): 97.45M for Sept. 30, 2024
View 4,000+ Financial Data Types:
Add
Browse
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amarin Corp PLC | 685.35M |
| DBV Technologies SA | 65.70M |
| Cellectis SA | 383.54M |
| Akari Therapeutics PLC | 2.734M |
| Biodexa Pharmaceuticals PLC | 17.67M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 123.79M |
| Shareholders Equity (Quarterly) | -26.34M |
| Debt to Equity Ratio | -3.106 |
| Current Ratio | 1.642 |
| Net Debt Paydown Yield | -53.20% |